ClinicalTrials.govpublic full text
Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer
advanced lung non-squamous non-small cell carcinoma, metastatic lung non-squamous non-small cell carcinoma, stage iii lung non-small cell cancer ajcc v7, stage iiia lung non-small cell cancer ajcc v7, stage iiib lung non-small cell cancer ajcc v7, stage iv lung non-small cell cancer ajcc v7, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 811306
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.